Terminated PHASE1 INTERVENTIONAL 4-arm NCT01021176

Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell

A Single Dose Pilot Study to Evaluate the Safety and Dose-Response of Smell to Intranasal Diltiazem

Sponsor: Compellis Pharmaceuticals

Updated 6 times since 2017 Last updated: Dec 17, 2015 Started: Oct 31, 2009 Primary completion: Nov 30, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

This PHASE1 trial investigates Food Intake and is currently terminated or withdrawn. Compellis Pharmaceuticals leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Compellis Pharmaceuticals
Pennington Biomedical Research Center

Data source: Pennington Biomedical Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baton Rouge, United States